A new robotic procedure is transforming how doctors detect and treat lung cancer, helping catch it earlier and improve ...
In a recent opinion piece published in the journal Trends in Cancer, researchers examined the rising global burden of lung cancer in people with no history of smoking. This phenomenon requires its own ...
NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...
bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results